Skip to main content

Table 3 miR-21 and RECK expression data in the malignant prostatic tissue according to Gleason score, Pathological stage, PSA value and Biochemical Recurrence

From: miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

 

miR-21

RECK

Gleason Score

  

< 7 (n = 22)

0.63

0.88

≥ 7 (n = 31)

0.81

2.10

p-value

0.545

0.214

Pathological Stage

  

pT2 (n = 22)

0,36

1.18

pT3 (n = 30)

1,01

1.85

p-value

0.009

0.470

PSA value

  

<10 (n = 27)

0.68

0.94

≥10 (n = 26)

0.80

2.18

p-value

0.701

0.390

Biochemical Recurrence

  

W/n (n = 27)

0.52

1.05

With (n = 20)

1.12

2.61

p-value

0.051

0.366

  1. Fold change in gene expression was calculated using the ΔΔCT method (QRel = 2-ΔΔCT).